This HTML5 document contains 141 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37978252
rdf:type
wikibase:Item
schema:description
scientific article published on 23 January 2012 videnskabelig artikel wissenschaftlicher Artikel articol științific наукова стаття, опублікована в січні 2012 artículu científicu artículo científico bilimsel makale vitskapeleg artikkel vedecký článok artigo científico article scientifique artikull shkencor מאמר מדעי vitenskapelig artikkel articolo scientifico artigo científico научни чланак artigo científico vědecký článek scientific article published on 23 January 2012 article científic مقالة علمية نشرت في 23 يناير 2012 artikel ilmiah scienca artikolo scientific article published on 23 January 2012 научная статья বৈজ্ঞানিক নিবন্ধ wetenschappelijk artikel vetenskaplig artikel
p:P577
wds:Q37978252-6B5F2D9D-E99C-43E9-9B9B-7403280DBC3E
wdt:P577
2012-01-23T00:00:00Z
p:P407
wds:Q37978252-069C8222-8B2A-4694-A06A-046823FBE9FD
wdt:P407
wd:Q1860
p:P2860
wds:Q37978252-82779B64-45EF-49DF-AD8F-D6C3CFA53FB7 wds:Q37978252-88408F76-F7E0-4AEF-928A-A21F2E17F274 wds:Q37978252-92687737-D9D9-412A-A8B4-9F6717479E18 wds:Q37978252-A030BB62-7A8B-4180-B551-A9C0A64422AB wds:Q37978252-A657B6A7-D56A-4D3C-82CF-35A896CC72AA wds:Q37978252-B76F7F01-CA9C-466A-A049-F42C37378860 wds:Q37978252-C24D0BCA-D755-4BAF-AA75-7725FABDCF2F wds:Q37978252-28A50012-F03C-47C5-A20C-801CD1A41178 wds:Q37978252-3A7D7ADF-B1B9-4B1B-8C04-CEDB501CC259 wds:Q37978252-4332AC6D-1F2C-4DBA-841C-34C9A00780A5 wds:Q37978252-55D468AA-6081-4F73-81FE-60DB3A93E77F wds:Q37978252-70A92E29-4060-4514-A0CF-6E73DDC32AC9 wds:Q37978252-75F33A80-D9F1-484B-975C-51D06ADCA39D wds:Q37978252-76E18742-5907-4568-ADD5-A4C4B8CFF692 wds:Q37978252-D5B3B916-518F-4B55-8654-D5CE8C038790 wds:Q37978252-D6F1698F-91C5-40D4-BA01-B7C4F5C7188B wds:Q37978252-0D22F1B9-C2C8-4826-B5C9-7DA3A3695A16 wds:Q37978252-101DFA70-30D0-46D8-B484-9FAF170B9E13 wds:Q37978252-157416AC-FF13-43F9-A3E4-DED8541A83A2 wds:Q37978252-16495080-942A-41E4-AC9F-173AC16B5920 wds:Q37978252-178B1F15-CD86-4021-B547-785E045043E3 wds:Q37978252-20871F50-FCA0-45EB-BF11-409FA2586E81 wds:Q37978252-7D9B0F4A-7E97-4510-A7ED-7BC1EA073A83 wds:Q37978252-824815F2-82AF-49BE-918F-AFAE39895D38
wdt:P2860
wd:Q40067209 wd:Q34578300 wd:Q37192522 wd:Q46153034 wd:Q36585424 wd:Q43997500 wd:Q33886458 wd:Q35597348 wd:Q34498486 wd:Q30832553 wd:Q24685403 wd:Q35606275 wd:Q33756929 wd:Q36228786 wd:Q30873996 wd:Q39759948 wd:Q43259606 wd:Q37084760 wd:Q45710994 wd:Q43847764 wd:Q40035493 wd:Q36360510 wd:Q41677898 wd:Q36027208
p:P2093
wds:Q37978252-4D84D3A0-BD16-4DE7-AB94-2E27E31CFCDE wds:Q37978252-5203EA67-1EDD-46AB-A6CC-8B7A436B2F05 wds:Q37978252-2857ED6E-0FD6-468C-9818-732EB9AF1D11
wdt:P2093
Eric Lerebours Jean-Louis Dupas Bernard Flourié
rdfs:label
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease
skos:prefLabel
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease
schema:name
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease
p:P50
wds:Q37978252-34D4F738-EA74-49EB-932E-B22AC94D6425 wds:Q37978252-B74D04D0-590C-4E80-84C0-329E29BBB355 wds:Q37978252-A4136324-7819-4882-8BDB-35F830DCB190 wds:Q37978252-90599DF2-CF18-42CF-B92F-7277D14C57AF wds:Q37978252-84579D7C-0189-4CB2-9519-29E5940524F0 wds:Q37978252-F30BCBC7-5778-44EC-A155-F17B064EB72B wds:Q37978252-1F2BFE41-63CA-424D-A84C-23668CC50F9F wds:Q37978252-24201F90-922B-4204-A25C-04B6BDA66218 wds:Q37978252-0451A1A7-6C8C-47D4-8513-C57A35BBBBD8 wds:Q37978252-084FEC02-72F9-491B-9FF1-BAA8B3C45711
wdt:P50
wd:Q30248039 wd:Q114416787 wd:Q42226814 wd:Q89946717 wd:Q30831170 wd:Q72537856 wd:Q114416786 wd:Q87725654 wd:Q56457827 wd:Q56382889
p:P1476
wds:Q37978252-B32DD60E-413C-4F23-A0D3-693AF7A49A5F
wdt:P1476
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease
p:P304
wds:Q37978252-DE045228-74E9-4B08-8F25-F6984C3EC902
wdt:P304
2063-2071
p:P31
wds:Q37978252-C79ADF86-68B6-45A3-B9C0-073927424C8B
wdt:P31
wd:Q13442814
p:P921
wds:Q37978252-6686BBFB-1AF7-4C0F-9125-569E3DE2C579 wds:Q37978252-2CFDDB94-169D-41E9-A330-E26F09A43629 wds:Q37978252-D271AD31-E872-4362-89AB-03A4D02D8C7D
wdt:P921
wd:Q4165484 wd:Q101991 wd:Q917447
p:P698
wds:Q37978252-A7B3D7C8-D944-4AFE-BB44-8310BF3B5704
wdtn:P698
n10:22271569
wdt:P698
22271569
p:P1433
wds:Q37978252-A98AE158-413C-47C9-A0BB-76090BD0A512
wdt:P1433
wd:Q15749161
p:P433
wds:Q37978252-2521B096-E08E-40E0-A9E7-2FE9137334F5
p:P478
wds:Q37978252-723970B2-98D4-4B5F-876B-9814FB4609B9
wdt:P433
11
wdt:P478
18
p:P356
wds:Q37978252-DBB54924-2AED-46C1-B27B-1FDE9F7D3A0C
wdtn:P356
n11:IBD.22889
wdt:P356
10.1002/IBD.22889
p:P5875
wds:Q37978252-5F9EAC25-B3A4-4D46-B7CC-773C1A23DC61
wdt:P5875
221772070